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Abstract  26 
The EphA4 receptor tyrosine kinase is involved in numerous cell-signalling activities 27 
during embryonic development. EphA4 has the ability to bind to both types of ephrin 28 
ligands, the ephrinAs and ephrinBs. The C57BL/6J-Epha4rb-2J/GrsrJ; genetically 29 
known as Epha4
rb-2J/rb-2J 
is a spontaneous mouse mutant which arose at The Jackson 30 
Laboratory. These mutants exhibited a synchronous hind limb locomotion defect or 31 
‘hopping gait’ phenotype, which is also characteristic of EphA4 null mice. Genetic 32 
complementation experiments suggested that Epha4
rb-2J 
corresponds to an allele of 33 
EphA4 but details of the genomic defect in this mouse mutant are currently 34 
unavailable. We found a single base-pair deletion in exon 9 resulting in a frame shift 35 
mutation that subsequently resulted in a premature stop codon. Analysis of the 36 
predicted structure of the truncated protein suggests that both the kinase and sterile α 37 
motif (SAM) domains are absent. We have also developed a method to ease detection 38 
of the mutation through RFLP that will aid in studies where the true genotypes need 39 
to be ascertained. The importance of this study is underlined by the numerous 40 
isoforms attributed to the Eph-ephrin family and in this case, the identification of the 41 
type of mutation enables further functional studies such as protein-protein 42 
interactions, immunostaining and gene compensatory studies of the Eph family of 43 
receptor tyrosine kinases. 44 
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Introduction 48 
Erythropoietin hepatocellular carcinoma receptor tyrosine kinases, more commonly 49 
known as the Ephs; are members of the largest family of receptor tyrosine kinases 50 
(RTKs) which characteristically bind to their ligand ephrins. The mammalian and 51 
chick Ephs are divided into two groups based on sequence homologies and affinity for 52 
ephrins, the A-type (EphA1-EphA10) and the B-type (EphB1-EphB6) (Pasquale, 53 
2008). EphrinAs are known to bind to EphA receptors and ephrinBs bind to EphBs. 54 
EphA4 interacts with both ephrinAs and ephrinBs (ephrinB2 and ephrinB3) and 55 
ephrinA5 binds to EphB2 (Himanen et al., 2004; Pasquale, 2004). Eph and ephrin 56 
signalling play many important roles including remodelling of blood vessels and 57 
formation of tissue boundary (Pasquale, 2005, 2008; Wilkinson, 2015). EphA4 has 58 
been shown to be involved in cell signalling activities in numerous contexts including 59 
axon guidance and development of central nervous system vasculature (Dottori et al., 60 
1998; Kullander et al., 2001).  61 
 During embryonic development, EphA4 is expressed at the tips of the closing 62 
spinal neural folds, and in the developing forebrain, hindbrain and mesoderm (Abdul-63 
Aziz et al., 2009; Nieto et al., 1992). In adult mice, EphA4 is highly expressed in the 64 
jejunum (Islam et al., 2010) and the brain, mainly in the hippocampus (Greferath et 65 
al., 2002; Grunwald et al., 2004; Kullander et al., 2001). Targeted mouse knockouts 66 
of the EphA4 gene display locomotor abnormalities of the hind limb resulting in a 67 
rabbit-like hopping movements (Coonan et al., 2001; Herrmann et al., 2010; 68 
Kullander et al., 2003; Kullander et al., 2001; Nieto et al., 1992) or clubfoot of the 69 
hind limb (Helmbacher et al., 2000). Interestingly, inactivation of the EphA4 function, 70 
which causes the lack of axonal guidance, was reported to promote axonal 71 
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regeneration and improve functional recovery of a central nervous system injury 72 
(Goldshmit et al., 2011). 73 
 Two spontaneous mutations of the EphA4 gene; Epha4
rb/rb
 (Eph receptor A4; 74 
rabbit) and Epha4
rb-2J/rb-2J 
(Eph receptor A4; rabbit 2 Jackson) were reported as 75 
spontaneous recessive mutants within the C57BL/6J background at The Jackson 76 
Laboratory. However, the exact genomic location of the mutated alleles has not been 77 
ascertained. Since the phenotype observed in the Epha4
rb-2J/rb-2J 
mice was very similar 78 
to the targeted knockouts of the EphA4 gene, complementarity testing was performed 79 
by mating a Epha4Gt(pGT1TM)38Wcs/+ female (provided by Tessier-Lavigne 80 
Laboratory of Stanford University) to an Epha4
rb-2J/+
 male. Among the progeny of 81 
this cross, 3 pups (1 female and 2 males) out of 7 exhibited hopping gait phenotype 82 
without leaning. The information on the Epha4
rb/rb
 and Epha4
rb-2J/rb-2J 
are from the 83 
Mouse Mutant Resource Web Site, The Jackson Laboratory, Bar Harbour, Maine. 84 
(http://mousemutant.jax.org/) [October 9, 2010]. This finding of genetic 85 
complementation strongly suggested that the rb-2J mutation lies within the EphA4 86 
gene. 87 
The aim of this study is to understand the nature of the Epha4
rb-2J/rb-2J
 88 
mutation and the extent of the mutation in the protein. Therefore it was necessary to 89 
define the mutation and determine the exact genotypes of the mice. We also reviewed 90 
the impact of the mutation with EphA4 isoforms and other reported EphA4 mutants to 91 
better understand the diversity of the EphA4 protein. In addition, we describe a rapid, 92 
simple assay for genotyping the C57BL/6J-Epha4rb-2J/GrsrJ mice, which was not 93 
previously available and will be invaluable to other groups intending to work with 94 
these mice. Therefore, we have addressed the knowledge gap for the C57BL/6J-95 
Epha4rb-2J/GrsrJ mouse in this study. 96 
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Materials and methods 97 
The Epha4
rb-2J/rb-2J 
strain (003129) was obtained from The Jackson Laboratory and the 98 
colony maintained at the Universiti Kebangsaan Malaysia’s Animal Biosafety Level 2 99 
laboratory. All experimental procedures were approved by the Institutional Animal 100 
Care and Use Committee (IACUC) of University of Malaya (approval number 101 
PAR/20/09/2011/NMAA). 102 
 103 
Epha4
rb-2J/rb-2J 
knockout mouse and dissection of the hippocampus  104 
As the hopping gait phenotype is only evident in mice at 3 weeks old, mutational 105 
analysis was first determined using samples from adult mice in order to correlate the 106 
genotype with an affected phenotype. In adult mice, EphA4 expression is abundant in 107 
the hippocampus (Liebl et al., 2003; Murai et al., 2003), therefore hippocampi of two 108 
aged matched control and Epha4
rb-2J/rb-2J 
mice were isolated (modified protocol) 109 
(Fuller & Dailey, 2007). The mice were euthanized by cervical dislocation. After the 110 
the midline incision from the foramen magnum was made up to the level of eye 111 
sockets, the skull flaps were tilted to break it off using forceps, and the brain was 112 
lifted out of the skull vault gently using curved narrow patterned forceps. In the clean 113 
petri dish, the brain was cut into half at the midline, and the hemisphere of the brain 114 
was held in place by piercing through the rostral end of the brain with Dumont 115 
forceps. Then, the brain stem and cerebellum were removed before gently removing 116 
the midbrain. The hippocampus is delineated along its length in the midbrain. The 117 
hippocampus was flipped over and cut to separate it from the hemisphere and stored 118 
in -80°C.  119 
 120 
RNA Isolation 121 
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RNA isolation was carried out by homogenisation in 1 ml of TRIzol (Invitrogen, 122 
Carlsbad, CA, USA) to 50 mg of hippocampi tissue, followed by the addition of 0.2 123 
ml chloroform according to the manufacturer’s instruction. After separation by cold 124 
centrifugation, the aqueous phase was placed in a new tube before addition of 0.5 ml 125 
of isopropanol and subsequently centrifuged. The pellet was washed with 75% 126 
ethanol and left to air-dry for 5-10 minutes. The pellet was then re-suspended in 127 
distilled, deionised water. 128 
 129 
Mutational screening of Epha4
rb-2J/rb-2J
 130 
Seven sets of primers, which amplify overlapping regions of EphA4 cDNA, were 131 
designed to allow sequencing of the entire coding region (accession number: 132 
NM_007936). After the discovery of location of the putative mutation in EphA4, 133 
primers for genomic DNA were also designed. All primers were designed using 134 
Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/primer3/). Primer sequences with 135 
overlapping region of EphA4 cDNA were as following: set 1 flanking exon 1 to 3 136 
(668 bp): 5’-CACCCTCTTGGCAATGTCTT-3’ and 5’-137 
CTTTTCAGGATGTGGGTGCT-3’; set 2 flanking exon 3 to 5 (700 bp): 5’-138 
GACATTGGTGACCGAATCAT-3’ and 5’-TCCACTACACACCACAGCAGA-3’; 139 
set 3 flanking exon 5 to 8 (588 bp):  5’-GGCCGTCAGGACATTTCTTA-3’ and 5’-140 
ACTCCACTGTCCTGCTGGTC-3’; set 4 flanking exon 7 to 11 (499 bp):  5’-141 
TCTGACTTCCTATGTTTTTCACG-3’ and 5’-GAGACTTCCTGAGTGAGGCC-3’; 142 
set 5 flanking exon 10 to 14 (578 bp): 5’-CGATGCATCCTGCATTAAAA-3’ and 5’-143 
CTCAGCCAGTGATGTCTGGA-3’; set 6 flanking exon 13 to 16 (515 bp):  5’-144 
CCGAAGCAGCCTACACTACC-3’ and 5’-TAGAAGCCGTGGTTCACATG-3’; 145 
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and set 7 flanking exon 15 to coding region exon 17 (471 bp):  5’- 146 
CTCCCCTGAATTCTCTGCTG-3’ and 5’-ATCAGAATTAAACCTGGAGCCA-3’. 147 
RT-PCR was performed using Transcriptor One-Step RT-PCR kit (Roche 148 
Diagnostics, Mannheim, Germany). The transcriptor enzymes mix contains 149 
transcriptor reverse transcriptase, expand system and protector RNase inhibitor. The 150 
1x reaction buffer including Tris, MgCl2, 1.5 mM dNTPs and additives for hot start 151 
PCR. We generated cDNA and amplified 50 ng of total RNA in a 50 ul of reaction 152 
mixture consisting of 0.4 uM of each primer. Glyceraldehyde 3-phosphate 153 
dehydrogenase (GAPDH) and Phosphoglycerate kinase 1, (Pgk1) mRNA were used 154 
as internal controls. The reverse transcription and amplification condition was set as 155 
follows: cDNA generation at 50
o
C for 30 minutes, and 94
o
C for 7 minutes, followed 156 
by 35 cycles of denaturation at 94
o
C for 10 seconds, annealing at optimised 157 
temperature for 30 seconds, extension at 68
o
C for 1 minute, with final extension at 158 
68
o
C for 7 minutes. Resulting PCR products were analysed by electrophoresis on 1% 159 
agarose gels containing ethidium bromide. 160 
  RT-PCR products from Epha4
+/+
, Epha4
rb-2J/+ 
and Epha4
rb-2J/rb-2J 
samples 161 
were purified using QIAquick PCR purification kit or QIAquick gel extraction kit 162 
(Qiagen, Valencia, CA, USA). All the purification steps were according to the 163 
manufacturer’s directions. Subsequently, 10 ul of 30 ng/ul single band PCR products 164 
were sent for Sanger sequencing through a commercial company. 165 
 166 
Genomic DNA Isolation and PCR 167 
While the mutational screening was performed on the coding transcripts, to enable 168 
ease of genotyping from the genomic DNA, we developed a method to genotype the 169 
mutation from genomic DNA. Tail or ear clips of adult mice were obtained and DNA 170 
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extraction for genotyping. The DNA extraction described previously (Sambrook et al., 171 
1989). The tissues were lysed in SNET buffer containing 20 mM Tris-Cl pH 8.0 172 
(Sigma), 5 mM EDTA pH 8.0 (Sigma), 400 mM NaCl (Sigma), 1% (w/v) SDS 173 
(Sigma) and sterilised by filtration through 0.45 µm nitrocellulose filter before the 174 
addition of 20 mg/ml Proteinase K (Sigma). The tissues were incubated in 55
o
C until 175 
the tissue was completely lysed. The DNA was isolated by using 1:1 of phenol 176 
solution (Sigma), followed by 2:1 of absolute ethanol precipitation and 70% ethanol 177 
washing step. After left to air-dry, the pellet was re-suspended in distilled, deionised 178 
water. 179 
The genomic DNA amplification of samples were performed with 0.6mM of 180 
EphA4 primers spanning the mutation (accession number: NC_000067.6; forward P1: 181 
5’-GTAACATGTGCACTGCCTATCC-3’ and reverse P2: 5’-182 
CACAGGCATATTAACCAACACTTC-3’) in a 50 ul total reaction of DreamTaq 183 
Green DNA polymerase (ThermoScientific), 1x buffer DreamTaq Green buffer 184 
including 2 mM MgCl2, and 0.2 mM dNTP. The amplification condition was set as 185 
follows: 95°C for 4 minutes, followed by 35 cycles of denaturation at 95°C for 1 186 
minute, annealing at 59°C for 1 minute, extension at 72°C for 1 minute, with final 187 
extension at 72°C for 10 minutes. The expected size of amplicon is 258 bp. 188 
Subsequently, 40 ul of 30 ng/ul single band PCR products were sent for DNA 189 
purification and Sanger sequencing through a commercial company. 190 
 191 
PCR- RFLP (Restriction Fragment Length Polymorphism) 192 
We employed PCR-RFLP to rapidly genotype the novel mutation in more samples. 193 
New primers were designed based on the Epha4
rb-2J/rb-2J
 exon 9 nucleotide sequence 194 
(http://bioinfo.ut.ee/primer3-0.4.0/primer3/) to introduce mutations into the amplified 195 
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DNA at nucleotide 1799 and 1800 (AATC) of the gene to generate an Xho1 196 
recognition site CTCGAG in mutant samples. The forward primer sequence (P3) is 197 
5’- TACAGCAAAGCGAAACTCGA-3’ (the altered sequence was underlined) and 198 
reverse primer sequence (P2) is 5’-CACAGGCATATTAACCAACACTTC-3’. We 199 
amplified 50ng of genomic DNA in a 20 µl of reaction mixture consisting of 0.5µM 200 
of each primer and 1X LightCycler® 480 Probe Master containing FastStart Taq 201 
DNA Polymerase, dNTP mix and 6.4mM MgCl2 (Roche Diagnostics, Mannheim, 202 
Germany). The amplification condition was set as follows: 95°C for 10 minutes, 203 
followed by 35 cycles of denaturation at 95°C for 10 seconds, annealing at 53°C for 204 
30 seconds, extension at 72°C for 10 seconds, with final extension at 72°C for 7 205 
minutes. Approximately 15µl of amplicon was digested with 20U of Xho1 (New 206 
England Biolabs, Ipswich, MA, USA) according to manufacturer’s protocol followed 207 
by separation on 4% agarose gel. The fragments generated were a single 149bp for the 208 
homozygote mutant, a single 166bp band for wildtype and two bands of 149bp and 209 
166bp bands for heterozygous profiles. 210 
 211 
Western Blot Analysis 212 
To determine the effect of the mutation, immunoblot analysis was performed using 213 
anti-EphA4 (EphA4 Antibody S-20; sc-921) and anti-GAPDH (Santa Cruz 214 
Biotechnology) on wildtype, heterozygous and mutant protein samples isolated from 215 
the hippocampi of 31-day old mice. Protein amounting to 25ug isolated from the 216 
hippocampi was mixed with 2µl of 1M DTT in a final volume of 20µl.  Protein 217 
samples were heated to 100°C for 10 minutes then immediately placed on ice prior to 218 
gel loading.  Life Technologies Xcel Surelock Mini Cell system was used with a 4-219 
12% denaturing precast protein gel according to the manufacturers guidelines. 220 
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Samples were run at 200V for 1 hour. Protein was then transferred using Life 221 
Technologies Xcel Mini Cell transfer system per manufacturers guidelines.  Protein 222 
was transferred at 35V for 3 hours with transfer apparatus submerged in ice 223 
bucket.  Blot was then blocked with 5% milk in TBS-T buffer (50mM Tris Base, 224 
150mM NaCl, 01% Tween 20, pH 7.5) for 1 hour.  After blocking, anti-EphA4 225 
primary antibody was diluted to 1:100 in 5% milk in TBS-T buffer and incubated 226 
with blot overnight at 4°C.  Anti-GAPDH primary antibody was added after 24 hours 227 
incubation with anti-EphA4 at a dilution of 1:50,000 and was incubated for an 228 
additional 1 hour at 4°C.  Blot was washed 5 times with TBS-T buffer for 5 minutes 229 
per wash with agitation. Secondary antibody (Life Technologies; A24531) was 230 
diluted 1:10,000 in 5% milk in TBS-T buffer and incubated with blot for 1 hour at 231 
room temperature. Blot was washed 5 times with TBS-T buffer for 5 minutes per 232 
wash with agitation.  Secondary antibody was detected by mixing equal volumes of 233 
ECL reagents (Pierce; 34077) and exposing the blot to the mixed ECL reagents for 5 234 
minutes. The blot was imaged on a BioRad chemidoc station. 235 
 236 
Results  237 
The Epha4
rb-2J/rb-2J 
mouse is commercially available from The Jackson Laboratory. 238 
However, the mutation was not known and there is no clear protocol on how to 239 
genotype these mice. Knowing the exact genotype is crucial when investigating the 240 
effect of the loss of the gene in the affected mice. Therefore, in this study we 241 
determined the precise mutation in the Epha4
rb-2J/rb-2J
 strain, confirming that EphA4 242 
loss of function is the cause of the phenotype in this strain and facilitating further 243 
experimental studies. 244 
 245 
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A single nucleotide deletion in Epha4
rb-2J/rb-2
 results in a truncated 246 
EphA4 protein
 
 247 
The EphA4 gene is 6,328bp in size located on mouse chromosome 1 248 
(Ensembl; release 80, May 2015). The sequences of the translated regions, contained 249 
within exon 1-17, of the Epha4
rb-2J/rb-2J 
strain were compared against the annotated 250 
EphA4 gene deposited in GenBank and with control C57BL/6J mice (accession 251 
number: NM_007936). A single nucleotide deletion (del1802) was located in exon 9 252 
at 77,390,062 on mouse chromosome 1 and confirmed by sequencing of genomic 253 
DNA. This deletion is predicted to result in a frame shift and creation of a premature 254 
stop codon (Figure 1A). The resultant protein is therefore predicted to consist of the 255 
wildtype sequence up to amino acid 582 (E582), followed by a series of six altered 256 
amino acids and a stop codon (Figure 1B). The mutation lies within a conserved 257 
protein region in several organisms including human, orang-utan, frog, pig, rat and 258 
chick (Table 1).  259 
This truncated protein lacks a further 390 amino acids compared to the full-260 
length wildtype protein, which has 986 amino acids (Figure 1B). The protein structure 261 
encoded by Epha4
rb-2J/rb-2J 
was predicted using Simple Modular Architecture Research 262 
Tool, SMART (http://smart.embl-heidelberg.de). The predicted structure of the 263 
truncated proteins lacks the kinase and sterile alpha motif (SAM) domains (Figure 264 
2E).  265 
 Western blot analysis (Figure 3) revealed an intact 110kDa band in samples 266 
from both wildtype and heterozygous mice. This band was absent in the homozygous 267 
mutant mice. A second band at 104kDa was detected in samples from all genotypes. 268 
We hypothesise that the lower molecular band is an alternate uncharacterised isoform. 269 
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There are no reported isoforms of EphA4 with only exon 9 (containing the truncating 270 
mutation) spliced out.  271 
 272 
An RFLP-PCR assay was developed to rapidly genotype the mice 273 
In addition to provide a means to identify mice carrying the deletion on exon 9, 274 
we analysed C57BL/6J-Epha4rb-2J/GrsrJ mouse colony with and without hopping 275 
gait characteristics using an inexpensive PCR-RFLP analysis (see Materials and 276 
Methods). The analysis showed Epha4
+/+
 mice with wildtype profile (a single 166 bp 277 
band), Epha4
rb-2J/+
 mice with heterozygous profile (two bands at 149bp and 166bp) 278 
and Epha4
rb-2J/rb-2J
 mice with mutant profile (a single 149bp band) (Figure 4). All the 279 
RLFP analyses were subsequently confirmed by DNA sequencing. All mutant mice 280 
were characterised with hopping gait features whereas both wildtype and 281 
heterozygous mice were apparently normal.  282 
 283 
Genotypes obtained correlate with the EphA4 phenotype 284 
Among 63 samples that were sequenced, 18 were wildtype (Epha4
+/+
), 35 285 
were heterozygous (Epha4
rb-2J/+
) and 10 were mutants (Epha4
rb-2J/rb-2J
).  The analysis 286 
showed that the deletion found on exon 9 of Epha4
rb-2J/rb-2J 
mice was 100% in 287 
concordance with the features observed in the mutant mice. 288 
 289 
Discussion  290 
The central pattern generators (CPGs) are the neuronal networks that generate and 291 
coordinate rhythmic limb movement. The hopping gait phenotype displayed by the 292 
EphA4 mutant was discovered due to CPG neurons aberrantly crossing the midline of 293 
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the spinal cord (Kullander et al., 2003). The crossing generates the synchronous 294 
locomotion of the hind limbs through reciprocal over-excitation of the CPG neurons.  295 
 Previous studies on the understanding of the functional domains of EphA4 296 
receptor in the mouse revealed the requirement of kinase function in axon guidance 297 
and its formation (Dufour et al., 2006; Egea et al., 2005; Kullander et al., 2001). The 298 
cytoplasmic domains of Eph receptor are the juxtamembrane (JM) domain, kinase 299 
domain, sterile-α-motif (SAM) domain and PDZ domain. In functional studies, the 300 
hopping gait phenotype only appeared in EphA4 mutants (EphA4
KD
) with a defective 301 
kinase domain (Kullander et al., 2001) and in mutants (EphA4
GFP
) with the absence of 302 
the entire functional cytoplasmic domains (Egea et al., 2005). Another EphA4 mutant 303 
(EphA4
EE
) displayed normal alternating gait when two mutations of tyrosine residues 304 
(Y596E and Y602E) were introduced in the JM domain (Egea et al., 2005). Despite 305 
the decrease of auto-phosphorylation in the mutant, there was an increase of basal 306 
kinase activity almost similar or higher than ephrin-activated EphA4. This would 307 
explain the requirement of kinase activity for normal functioning CPG neurons and 308 
normal alternating gait. The findings support the hypothesis that tyrosine residues in 309 
the JM domain regulate EphA4 kinase activity. The mutation in Epha4
rb-2J/rb-2J 
is 310 
located at E582 prior to the major auto-phosphorylation sites. The deletion resulted in 311 
a frameshift, leading upon translation to altered six encoded codons followed by a 312 
stop codon. The Epha4
rb-2J/rb-2J
 protein
 
is truncated, lacking the tyrosine auto-313 
phosphorylations sites in the JM domain, the kinase domain, SAM domain and PDZ 314 
domain. The phenotype of the Epha4
rb-2J/rb-2J
 mouse differs from the other EphA4 315 
mutants that have been published in the past in that it not only hops but also leans.  316 
Therefore, variability in phenotypic representations exists from the same gene 317 
knockouts (Table 2). 318 
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The kinase activity of the Epha4
rb-2J/rb-2J 
protein is expected to be low to almost 319 
non-existent similar to previously reported mutants. Truncation of EphA4 was 320 
indicated by the western blot analysis, which showed the absence of the full length 321 
EphA4 protein (110kDa) in homozygote mutant mice. A second band similar to 322 
smaller isoform reported in UniProt 323 
(http://www.uniprot.org/uniprot/?query=EphA4&sort=score) at 104kDa was detected 324 
in wildtype, heterozygous and mutant EphA4 mice. However, this band is most likely 325 
an unknown isoform, which has exon 9, spliced out but it still possesses the epitope 326 
located at the SAM domain, which is detected by the Santa Cruz antibody. 327 
 There exists 7 isoforms of the EphA4 protein (available from UniProt; Table 328 
3). It seems likely that the Epha4
rb-2J/rb-2J 
protein exists in two spliced variations. The 329 
first being that the full length version is mutated and lacks the kinase domain; 330 
therefore the signal from the full length version is not picked up by the western blot in 331 
Figure 3 but possesses an unknown shorter isoform at 104 kDa (similar in size but 332 
differs from Figure 2C). The truncated full length version of Epha4
rb-2J/rb-2J 
is 63 kDa 333 
in size when analysed using SMART prediction (Figure 2E) and it is similar in size to 334 
the 63 kDa short isoform of EphA4 (Figure 2D). Ephs and ephrins are known to carry 335 
spliced variations of its protein as evidenced in both man (Finne et al. 2004) and 336 
mouse (Holmberg et al. 2000). 337 
 338 
Conclusions  339 
We identified a single nucleotide deletion of adenine in exon 9 of EphA4 in the 340 
Epha4
rb-2J/rb-2J
 mouse mutant. This deletion results in a frameshift, which is predicted 341 
to cause premature truncation of the protein, and lack of key cytoplasmic domains. 342 
This data is important in validating experiments that utilises the Epha4
rb-2J/rb-2J
 343 
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knockout mouse to look at the function of the EphA4 gene. Furthermore, this study 344 
underlines the numerous isoforms of the EphA4 gene and the variability in phenotype 345 
arising from which isoform becomes the major gene product.346 
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Tables 453 
Table 1. Epha4
rb-2J/rb-2J 
mutation lies within a conserved region. Alignment of 454 
Epha4
rb-2J/rb-2J 
protein sequences of different organisms including human, rat and Xenopus, 455 
revealed the spontaneous mutation was in a conserved region. 456 
Organism Amino acids 
EphA4 wildtype (mouse) AKQEADEEKHL….. 
EphA4 mutant (mouse) AKQEQMKRNI-stop 
Human AKQEADEEKHL….. 
Orangutan AKQEADEEKHL… 
Xenopus AKQEADEEKHL…. 
Pig AKQEADEEKHL…. 
Rat AKQEADEEKHL…. 
Chick AKQEADEEKHL… 
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Table 2. Phenotypes of EphA4 mutation mice based on position of mutation 457 
Position of mutation EphA4 mutations  Type of knockout and 
method 
Phenotype and anatomical defects References 
Exon 1 knockout and 
exone 3 frame shift 
mutation 
EphA4
-
 Replacement vector; lac-Z 
reporter fusion 
Hind limb phenotype (“club foot”) high 
penetrance 
Loss of dorsal hindlimb innervation (peroneal 
nerve); absent anterior commissure 
Helmbacher et al. 2000 
Ligand binding domain 
(exon 3) 
EphA4
0
 Gene replacement pgk-neo Kangaroo-like (ROO) hopping gait.  
Abnormal corticolspinal tract (CST) axons; absent 
anterior commissure 
Dottori et al. 1998; Coonan 
et al., 2001 
Extracellular region (exon 
3) 
EphA4
EGFP
 Insertion of EGFP 
(reporter) 
Hopping gait Grunwald et al. 2004 
Deletion of exon 3 EphA4 conditional; 
EphA4
Flox 
Knock-in mCFP  reporter 
gene; targerted 
(floxed/Frt) 
Hind limb hopping gait Herrmann et al. 2010 
Deletion of exon 3 EphA4 null Knock-in mCFP  reporter 
gene 
Hind limb hopping gait Herrmann et al. 2010 
Entire intracellular is 
missing 
EphA4
GFP
 Entire intracellular part 
was replaced by green 
fluorescent protein (GFP) 
Hopping gait Egea et al., 2005 
Fibronectin domain 
(abberant amino acids 
after position 439._ and 
truncation at position 442. 
T>C intron 6 at position 
113891 mutation 
(NC_000067). Possibilty, 
splicing of exon 6 and 
frameshift that create stop 
codon early in exon 7.  
Frog Chemical induced (ENU) Hopping gait 
 
Milstein et al., 2010 
Juxtamembrane domain 
(Y596E and Y602E) 
EphA4
EE
 Knock-in strategy (similar 
to Kullander 2001), 
replacement vector—
glutamic acid residues 
replace juxtamembrane 
tyrosines 
Normal alternating gait. No discernible phenotype. 
Abnormal thalamocortical topography; and partly 
defective central paatern generator (CPG) 
rhythmicity. 
Egea et al., 2005 
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Juxtamembrane domain 
(Y596F and Y604F) 
EphA4
2F
 EphA4 Knock-in strategy 
(targeting vectors) 
Hopping gait Kullander et al. 2001 
Kinase domain and 
truncated at E582. 
Deletion adenine at 1802 
(NM_007936) 
 
EphA4
rb-2J
 Spontaneous mutation Hopping gait and leaning Mohd-Zin et al., this study; 
Cook et al.,  2004 
Kinase domain (K653M) EphA4
KD
 EphA4 Knock-in strategy 
(targeting vectors); kinase 
dead 
Hopping gait 
Signalling mutants: abnormal signalling mutants 
hopping gait; anterior commissure 
Kullander et al. 2001 
SAM domain (905-974 
amino acids deletion); 
leaving 12 last amino 
acids residues intact 
EphA4
ΔSAM
 
 
EphA4 Knock-in strategy 
(targeting vectors) 
Normal alternating gait Kullander et al. 2001 
PDZ-binding motif and 12 
last amino acids of EphA4 
gene 
EphA4
ΔPBM
 
 
Knock-in Not described  Dufour et al. 2006 
Not described EphA4
PLAP
 Gene trapped, insertion of 
PLAP vector 
Hopping kangaroo gait 
Guidance defects in the CST (crossing defects of 
axons) and anterior commissure. However, low 
expression of EphA4 in CST neurons. 
Leighton et al., 2001 
Not described PGK-cre;EphA4
lx 
Recombination of PGK-
Cre and EphA4
lox/lox
 
Kangaroo-like (ROO) hopping gait.  
Abnormal formation of anterior commissure and 
significant reduction of CST axons 
Filosa et al. 2009 
Not desribed Conditional EphA4; 
EphA4
lx 
Targeted (floxed/frt) Normal alternating gait 
EphA4 expression in control EphA4
lx/lx 
mice is 
reduced to 15–20% compared to +/+ mice 
Filosa et al. 2009 
Not studied EphA4
rb
 Spontaneous mutation Normal alternating gait Cook et al, 2004 
Different type of mutations showed most with hind limb hopping gait phenotypes (bold) and few with normal alternating gait phenotypes 458 
(underlined). 459 
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Table 3 460 
UniProt ID*** Size of 
transcript 
(bp)* 
Protein (aa, 
amino 
acids) 
Size (Da) Aligned to Q03137 
(position) 
Domain(s) 
Q03137 
Long isoform 
(Experimental 
evidence at protein 
level) 
6328 986 aa 109,814 1-986 aa Ligand binding domain (30-209 aa), cysteine rich domain (191-325 
aa), fibronectin type III domain (328-439 aa & 440-537 aa), 
juxtamembrane domain, protein kinase domain (621-882 aa), SAM 
domain (911-975 aa), PDZ-binding motif (984-986 aa)** 
Q03137-2 
Shorter isoform 
(No experimental 
confirmation 
available) 
No information 936 aa 103,984 Missing 783-832 aa 
(missing protein 
kinase domain). 
Missing whole exon 
14. 
Ligand binding domain, fibronectin type III domain, juxtamembrane 
domain, SAM domain 
Q3V1W9  
Short isoform 
(Experimental 
evidence at 
transcript level) 
No information 572 aa 63,034 Da Missing whole exon 
9-17 (missing 
juxtamembrane 
domain, kinase 
domain, SAM 
domain and PDZ-
binding motif) 
Ligand binding domain, fibronectin type III domain 
A0A087WRH4 
(Experimental 
evidence at protein 
level) 
614 117 aa 13,206 833-949 aa (whole 
exon 15&16) 
SAM domain 
A0A087WQW6 
(Experimental 
evidence at protein 
level) 
584 177 aa 19,075 328 to 473 aa (exon 
5&6) 
Fibronectin type III 
Q99KA8 
(Experimental 
evidence at 
transcript level) 
No information 927 aa 103,444 Missing 1-59 aa 
(ligand binding 
domain is not 
affected) 
Ligand binding domain, fibronectin type III domain, juxtamembrane 
domain, protein kinase domain, SAM domain 
A0A087WQZ6 
(Protein Predicted)  
3043 38 aa 4,137 1-38 aa (missing 
the rest of domains) 
No information 
*Information obtained from Ensembl (http://asia.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000026235;r=1:77367185-77515088) 461 
**Information obtained from UniProt (http://www.uniprot.org/uniprot/Q03137#showFeatures) 462 
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***Note: (taken from UniProt last modified January 8, 2015) 463 
The value ‘Experimental evidence at protein level’ indicates that there is clear experimental evidence for the existence of the protein. The criteria include partial or 464 
complete Edman sequencing, clear identification by mass spectrometry, X-ray or NMR structure, good quality protein-protein interaction or detection of the protein by 465 
antibodies. 466 
The value ‘Experimental evidence at transcript level’ indicates that the existence of a protein has not been strictly proven but that expression data (such as existence of 467 
cDNA(s), RT-PCR or Northern blots) indicate the existence of a transcript. 468 
The value ‘Protein Predicted’ is used for entries without evidence at protein, transcript, or homology levels. 469 
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Legends 470 
Figure 1. A single nucleotide deletion in exon 9 of Epha4
rb-2J/rb-2J
 471 
A, The deletion of adenine at nucleotide 1,802 or 1,803 in exon 9 of EphA4 gene (indicated 472 
by an arrowhead). B, Nucleotide and deduced amino acid sequence of the Epha4
+/+ 
and 473 
Epha4
rb-2J/rb-2J
. The deletion in EphA4 (highlighted by the red box) resulted in a frame shift of 474 
downstream codons and a premature termination. 475 
 476 
Figure 2. A schematic representation of Eph receptor, Epha4
+/+
and Epha4
rb-2J/rb-2J 
477 
structure 478 
A, A general structure of an Eph receptor. B, The predicted structures using Simple Modular 479 
Architecture Research Tool, SMART for Epha4
+/+
. C, SMART structure of EphA4 isoform at 480 
104 kD lacking kinase domain but possesses SAM domain. D, SMART structure of EphA4 481 
isoform at 63 kDa which is truncated downstream of the juxtamembrane domain. E, The 482 
Epha4
rb-2J/rb-2J
 structure by SMART showing truncation downstream of the juxtamembrane 483 
domain, lacking the kinase and SAM domains.  484 
 485 
Figure 3. EphA4 protein expression 486 
Western blot analysis of EphA4 immunostaining showed that the EphA4 mutant mice lacked 487 
the expression of the 110kDa full-length protein but detected a second band similar to EphA4 488 
isoform at 104 kDa (UniProt). The 110kDa full-length protein was detected in the EphA4 489 
wildtype profile and heterozygous mice. 490 
 491 
Figure 4. A representative PCR-RFLP analysis of the Epha4
rb-2J/rb-2J 
mice genotypes 492 
PCR-RFLP samples were resolved in 4% agarose gel. Lanes 1-3 represent the wildtype 493 
profiles (166bp band only), Lanes 4-6 represent the heterozygote profiles (149bp and 166bp 494 
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bands), Lanes 7-9 represents the homozygote mutant profiles (149bp band only) and Lane 10 495 
represents the 50bp ladder. 496 
497 
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